Irish Jian, CEO of Metagenomi, Inc. ($MGX), sold shares on the open market four times over the past year, totaling about $19,500. His most recent sale occurred on March 5, 2026. These sales rank 11,055th among 11,678 individual insiders, far below the average of $8.6 million per seller and 6.4 transactions. Jian made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 276000 | $0.00 | 276,000.0000 | 37,546,751 | 9999.99% | 0.74% |
| April 1, 2026 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Common Stock | 46000 | $0.00 | 965,197.0000 | 37,546,751 | 5.00% | 0.12% |
| March 5, 2026 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | S | Common Stock | 1607 | $1.60 | 919,197.0000 | 37,546,751 | 0.17% | 0.00% |
| Dec. 5, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | G | Common Stock | 228462 | $0.00 | 920,804.0000 | 37,546,751 | 19.88% | 0.61% |
| Dec. 5, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | S | Common Stock | 1602 | $1.77 | 563,839.0000 | 37,546,751 | 0.28% | 0.00% |
| Dec. 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | A | Common Stock | 211000 | $1.60 | 565,441.0000 | 37,546,751 | 59.53% | 0.56% |
| Sept. 5, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | S | Common Stock | 1602 | $1.81 | 316,941.0000 | 1,870,923 | 0.50% | 0.09% |
| Dec. 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | A | Common Stock | 37500 | $1.60 | 354,441.0000 | 37,546,751 | 11.83% | 0.10% |
| Dec. 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | Chief Executive Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 37,546,751 | 9999.99% | 0.60% |
| June 6, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | S | Common Stock | 6390 | $1.75 | 315,543.0000 | 1,870,923 | 1.98% | 0.34% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 1,870,923 | 9999.99% | 7.48% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Common Stock | 23000 | $0.00 | 678,898.0000 | 1,870,923 | 3.51% | 1.23% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Stock Option (Right to Buy) | 296308 | $0.00 | 296,308.0000 | 3,884,740 | 9999.99% | 7.63% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Irish Jian | See Remarks | A | Common Stock | 70471 | $0.00 | 655,898.0000 | 3,884,740 | 12.04% | 1.81% |